CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE Primary Prevention of Heart Failure in Women Optical coherence tomography and intravascular ultrasound assessment of the anatomic size and wall thickness of a muscle bridge segment Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling Circadian-Regulated Cell Death in Cardiovascular Diseases A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)

Original Research2021 Jan 5;1-10.

JOURNAL:J Natl Compr Canc Netw. Article Link

Risk of Cardiovascular Diseases Among Older Breast Cancer Survivors in the United States: A Matched Cohort Study

AA Matthews, SP Hinton, S Stanway et al. Keywords: breast cancer; CVD; screening and monitoring

Full Text PDF